Adagio Medical Holdings (ADGM) Return on Sales (2023 - 2025)

Name: Adagio Medical Holdings (ADGM) Return on Sales (2023 - 2025) | Business Quant
Creator: Business Quant

Adagio Medical Holdings (ADGM) reported Return on Sales of 1.84% for Q4 2025, down 261.14% on a QoQ basis from 0.51% in Q3 2025.

Adagio Medical Holdings (ADGM) has 3 years of Return on Sales data on file, last reported at 1.84% in Q4 2025.

Quarterly Return on Sales changed N/A year-over-year to 1.84% in Q4 2025, while the trailing twelve-month figure through Dec 2025 was 1.84% (changed N/A YoY) and the FY2024 annual result came in at 2.35%, down 136.0% from the prior year.
Return on Sales fell to 1.84% in Q4 2025 per ADGM's latest filing, from 0.51% in the prior quarter.
Across five years, Return on Sales topped out at 0.29% in Q2 2024 and bottomed at 3.68% in Q1 2024.
The 3-year median for Return on Sales is 0.63% (2025), against an average of 1.28%.
Peak annual rise in Return on Sales reached 319 bps in 2025, while the deepest fall reached 15 bps in 2025.
Tracing ADGM's Return on Sales over 3 years: stood at 0.76% in 2023, then jumped by 53 bps to 0.36% in 2024, then plunged by 416 bps to 1.84% in 2025.
Per Business Quant, the three latest ADGM Return on Sales figures stand at 1.84% (Q4 2025), 0.51% (Q3 2025), and 0.49% (Q1 2025).

Peer Comparison

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	ROS (Qtr)
1	Abbott Laboratories	152.82 Bn	146.17 Bn	6.27 Bn	0.00%
2	Stryker	115.07 Bn	112.19 Bn	3.81 Bn	0.00%
3	Medtronic	95.25 Bn	87.08 Bn	5.76 Bn	0.00%
4	Boston Scientific	71.38 Bn	70.17 Bn	3.61 Bn	0.00%
5	Edwards Lifesciences	51.08 Bn	47.41 Bn	1.29 Bn	0.00%
6	Koninklijke Philips	29.38 Bn	26.07 Bn	2.07 Bn	0.00%
7	Dexcom	28.84 Bn	27.72 Bn	750.30 Mn	0.00%
8	GE HealthCare Technologies	28.56 Bn	26.49 Bn	1.98 Bn	0.00%
9	Steris	20.71 Bn	20.30 Bn	697.10 Mn	-
10	Adagio Medical Holdings	16.86 Mn	3.95 Mn	-	-

Download Data 🔒